CBD drugs moved to Schedule 5; no promises for cannabis
The DEA has moved CBD prescription drugs with THC levels below .01% to a Schedule 5 drug after the FDA's approval of Epidolex. However, despite …
The DEA has moved CBD prescription drugs with THC levels below .01% to a Schedule 5 drug after the FDA's approval of Epidolex. However, despite …